Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Halozyme Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Halozyme Therapeutics

Halozyme Therapeutics

Public

Halozyme Therapeutics, Inc.: A biotech firm innovating in diabetes, cancer, dermatology, and drug delivery.

HQ
San Diego, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Halozyme Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative products for the diabetes, cancer, dermatology, and drug delivery markets. Founded in 1998 and headquartered in San Diego, California, Halozyme leverages its proprietary recombinant human hyaluronidase platform technology to enhance drug delivery and efficacy. The company collaborates with pharmaceutical partners to apply its technology across various therapeutic areas, aiming to improve patient outcomes and ease the burden of treatment.

Halozyme has made significant strides in the biotech industry, becoming a publicly traded company on Nasdaq under the ticker HALO and a component of the S&P 400. Its disruptive drug delivery technologies have garnered attention for their potential to transform patient care. The company's commitment to innovation and patient-centric solutions has solidified its reputation as a leader in the biopharmaceutical sector.

Halozyme Therapeutics - Similar Companies

Zenomics logo

Zenomics

Heron Therapeutics logo

Heron Therapeutics

herontx.com

Denali Therapeutics logo

Denali Therapeutics

Gyre Therapeutics logo

Gyre Therapeutics

Extend Biosciences logo

Extend Biosciences

extendbio.com

InSitu Biologics logo

InSitu Biologics

Enable Therapeutics logo

Enable Therapeutics

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

LayerBio logo

LayerBio

layerbio.com

Nurix logo

Nurix

nurixtx.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Genentech logo

Genentech

gene.com

Zymeron logo

Zymeron

zymeron.com

Halia Therapeutics logo

Halia Therapeutics

Halda Therapeutics logo

Halda Therapeutics

haldatx.com

Halozyme Therapeutics - Quick Facts

Who are Halozyme Therapeutics' competitors?

Companies similar to Halozyme Therapeutics include Zenomics, Heron Therapeutics, Denali Therapeutics and Gyre Therapeutics.

When was Halozyme Therapeutics founded?

Halozyme Therapeutics was founded in 1998.

Where is Halozyme Therapeutics' headquarters located?

Halozyme Therapeutics' headquarters is located in San Diego, CA, US.

When was Halozyme Therapeutics' last funding round?

Halozyme Therapeutics' most recent funding round was for $500M (USD) in August 2022.

How much has Halozyme Therapeutics raised to-date?

As of Aug 15, 2022, Halozyme Therapeutics has raised a total of $745M (USD).

How many employees does Halozyme Therapeutics have?

Halozyme Therapeutics has 393 employees as of Feb 6, 2024.

Halozyme Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthtech
Unique IDs
  • secCik: 0001159036
  • ticker: HALO
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4400Water Transportation
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research